Click a link below to view the mailing archive as if it had been sent to you.
2017-11-30 12:15 | | In Search Of Novelty: 2017's New FDA Drug Approvals and more... |
2017-11-30 00:15 | | Regeneron and Decibel aren’t just collaborating: They want to create a whole new partnering model and more... |
2017-11-29 12:15 | | One big Novartis takeaway from Entresto's slow start? Heart failure doesn't work like oncology and more... |
2017-11-29 00:15 | | Which trends will impact pharma marketers in 2018? InVentiv has a few ideas and more... |
2017-11-28 12:15 | | FDA Boss Aims To Close EpiPen Loophole and more... |
2017-11-28 00:15 | | How much is an FDA shortcut worth to drug developers hustling to an OK? Holding steady at $125M, cash and more... |
2017-11-27 12:15 | | Roiled by financial turmoil, Teva’s CEO boots R&D chief, top execs in C-suite overhaul and more... |
2017-11-26 00:15 | | J&J & Glaxo's Jucala Approval Puts Spotlight on HIV Space and more... |
2017-11-24 12:15 | | Teva R&D chief out as new CEO picks up the ax and aims at deep cuts to rescue a faltering biopharma — report and more... |
2017-11-22 12:15 | | Takeda spins off cancer assets to incubated startup and more... |
2017-11-22 00:15 | | With billions riding on their success, GSK bags quick OK for its two-drug HIV combo Juluca and more... |
2017-11-21 12:15 | | Allergan could sell women's health for $6B, if it would only agree to split: analyst and more... |
2017-11-21 00:15 | | FDA adds ‘breakthrough’ status for Alnylam as patisiran starts its victory lap at the agency and more... |
2017-11-20 12:15 | | GlaxoSmithKline's Nucala, buoyed by its medical organization, ready to 'fiercely compete' with AstraZeneca and more... |
2017-11-19 12:15 | | U.S. biotechs can’t shake October blues as investors await next moves and more... |
2017-11-19 00:15 | | [video]Is Loxo Oncology's Deal With Bayer Bad News? and more... |
2017-11-18 12:15 | | Nevada refusing Pfizer demand for return of execution drugs and more... |
2017-11-17 12:15 | | Cancer Space Update: Label Expansion for Three Major Drugs and more... |
2017-11-17 00:15 | | Drug firm founder pleads not guilty to opioid bribe scheme and more... |
2017-11-16 12:15 | | How can new launches mimic Keytruda, Harvoni, and Opdivo? A new report has some ideas and more... |
2017-11-16 00:15 | | Alkermes touts equal efficacy of monthly Vivitrol against daily Suboxone and more... |
2017-11-15 12:15 | | Relax, pharma. Amazon's eyeing medical and device sales before drugs: report and more... |
2017-11-15 00:15 | | Hospitals file lawsuit to block 340B drug payment cut and more... |
2017-11-14 12:15 | | FDA eyes even more pricing competition with another round of generics moves and more... |
2017-11-14 00:15 | | Forget BMS. Pfizer should chase a Biogen buy, analyst suggests and more... |
2017-11-13 12:15 | | Trump nominates former pharma exec Azar to head HHS and more... |
2017-11-13 00:15 | | Last week in pharma.bio.device.lab November 5-11 2017 |
2017-11-12 12:15 | | An explosion of PD-1/L1 checkpoint studies is crowding the industry pipeline — and that’s a problem and more... |
2017-11-11 12:15 | | After months of searching, Immunomedics lines up Celgene vet Pehl as its new CEO and more... |
2017-11-11 00:15 | | Juno analysis of shuttered study offers clues for CAR-T and more... |
2017-11-10 12:15 | | Bristol-Myers offers a positive snapshot on early data for an IDO1 rival to Incyte and more... |
2017-11-10 00:15 | | AstraZeneca Stock Gains as Crestor Sales Decline Slows and more... |
2017-11-09 12:15 | | [forum discussion]RIP Novo and more... |
2017-11-09 00:15 | | Amgen Challenge of FDA Decision on Pediatric Exclusivity Could Have Wider Implications and more... |
2017-11-08 12:15 | | Limits on pharma payments to doctors back on policy menu and more... |
2017-11-08 00:15 | | Allergan executives named in investor suit over alleged generics price fixing and more... |
2017-11-07 12:15 | | Drugstore pain pills as effective as opioids in ER patients and more... |
2017-11-07 00:15 | | Roche job cuts mount to 365 as drugmaker rethinks packaging and more... |
2017-11-06 12:15 | | Trump readies executive order to unravel Obamacare's individual mandate and more... |
2017-11-05 12:15 | | Allergan CEO Saunders claims 'tenacity' led company into tribal licensing deal and more... |
2017-11-05 00:15 | | Amgen and Genentech are the latest drug makers to lay off workers and more... |
2017-11-04 12:15 | | Mallinckrodt continues pipeline revamp with Ocera buy and more... |
2017-11-03 12:15 | | GSK and Gilead go head to head as HIV drugs enter new phase and more... |
2017-11-03 00:15 | | Most New Drug Patents Are for Old Remedies, Research Shows and more... |
2017-11-02 12:15 | | EpiPen Failures Cited in Seven Deaths This Year, FDA Files Show and more... |
2017-11-02 00:15 | | Verastem moves closer to US filing for blood cancer drug and more... |
2017-11-01 12:15 | | Bristol-Myers Squibb could double patient numbers for Opdivo in kidney cancer and more... |
2017-11-01 00:15 | | AstraZeneca wins US approval for lymphoma drug and more... |